Global Cancer Genomic Testing market cagr 12.20%

Cancer Genomic Testing Market

Cancer Genomic Testing Market Scope: Industry

Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Cancer Genomic Testing Market Size and Growth

The global Cancer Genomic Testing market is experiencing significant growth due to increasing prevalence of cancer, advancements in genomic technology, and rising demand for personalized medicine. The market size is estimated to reach $XX billion by 2025. Key players are focusing on strategic collaborations and product innovations to gain a competitive edge. Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Myriad Genetics

◍ Centogene AG

◍ Color Genomics

◍ Quest Diagnostics

◍ 23andMe Inc.

◍ Gene By Gene Ltd.

◍ LabCorp

◍ Positive Bioscience

◍ Bio-Rad Laboratories

◍ Illumina, Inc.

◍ Agilent Technologies

◍ Thermo Fisher Scientific

The competitive landscape of the Cancer Genomic Testing Market includes key players like Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience, Bio-Rad Laboratories, Illumina, Inc., Agilent Technologies, Thermo Fisher Scientific. These companies offer a range of genomic testing services, including genetic predisposition testing, tumor profiling, and treatment response monitoring. They drive market growth by investing in research and development, expanding their testing capabilities, and forming strategic partnerships with healthcare providers.

- Myriad Genetics reported sales revenue of $771.30 million in 2020.

- Quest Diagnostics reported sales revenue of $9.44 billion in 2020.

- LabCorp reported sales revenue of $11.53 billion in 2020.

Request Sample Report

Market Segmentation

By Application

◍ Hospitals

◍ Clinics

◍ Diagnostic Laboratories

◍ Academic and Research Institutes

◍ Others

By Product

◍ Breast Cancer Genomic Testing

◍ Lung Cancer Genomic Testing

◍ Blood Cancer Genomic Testing

◍ Liver Cancer Genomic Testing

◍ Stomach Cancer Genomic Testing

◍ Others

Request Sample Report

$ 56.53 Billion

Request Sample Report